LEGN
Legend Biotech Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
Legend Biotech Corp
21.63
No thesis.
Expected move
No implied move.
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $840.2M | 27.98% | +13.22% | |
| 2 | Deerfield ManagementDeerfield | $235.0M | 7.83% | +5.85% | |
| 3 | Suvretta Capital ManagementSuvretta | $204.2M | 6.80% | −6.74% | |
| 4 | Hillhouse Capital AdvisorsHillhouse Capital | $172.8M | 5.75% | 0.00% | |
| 5 | BlackRockBlackRockindex-like | $136.5M | 4.54% | +0.90% | |
| 6 | Westfield Capital ManagementWestfield | $127.9M | 4.26% | −23.14% | |
| 7 | Goldman Sachs GroupGoldman Sachs | $105.8M | 3.52% | +150.14% | |
| 8 | Point72 Asset ManagementPoint72 | $88.8M | 2.96% | −20.84% | |
| 9 | Kynam Capital ManagementKynam | $86.7M | 2.89% | +90.40% | |
| 10 | Assenagon Asset ManagementAssenagon | $55.3M | 1.84% | new | |
| 11 | Artisan Partners Limited PartnershipArtisan Partners Limited Partnership | $45.0M | 1.50% | −30.83% | |
| 12 | State StreetState Streetindex-like | $43.3M | 1.44% | +0.02% | |
| 13 | Capital International InvestorsCapital International Investors | $41.0M | 1.37% | +119.29% | |
| 14 | Morgan StanleyMorgan Stanley | $40.3M | 1.34% | +131.17% | |
| 15 | Soleus Capital ManagementSoleus | $34.8M | 1.16% | new | |
| 16 | Davern Capital PartnersDavern Capital Partners | $34.4M | 1.15% | −9.37% | |
| 17 | Driehaus Capital ManagementDriehaus | $33.5M | 1.11% | new | |
| 18 | Renaissance TechnologiesRenaissance Technologies | $28.9M | 0.96% | +91.68% | |
| 19 | Ghisallo Capital ManagementGhisallo | $28.9M | 0.96% | new | |
| 20 | Matthews International Capital ManagementMatthews International | $26.5M | 0.88% | −0.93% | |
| 21 | Johnson & JohnsonJohnson & Johnson | $23.5M | 0.78% | 0.00% | |
| 22 | IvyRock Asset Management (HK)IvyRock Asset Management (HK) | $23.1M | 0.77% | −0.37% | |
| 23 | EcoR1 CapitalEcoR1 Capital | $23.1M | 0.77% | new | |
| 24 | JPMorgan ChaseJPMorgan Chase | $22.5M | 0.75% | new | |
| 25 | Squarepoint OpsSquarepoint Ops | $22.2M | 0.74% | +60.43% |
221 managers report $3.0B of Legend Biotech on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; FMR is largest at 27.98%.
No N-PORT holders.
News
News